117 related articles for article (PubMed ID: 38047468)
21. Synthesis of novel nicotinic acid derivatives of potential antioxidant and anticancer activity.
El-Dash Y; Khalil NA; Ahmed EM; Hassanin SO; Gowifel AMH; Hassan MSA
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300250. PubMed ID: 37792247
[TBL] [Abstract][Full Text] [Related]
22. Bio Prospecting of Marine-derived Streptomyces spectabilis VITJS10 and Exploring its Cytotoxicity Against Human Liver Cancer Cell Lines.
Selvakumar JN; Chandrasekaran SD; Vaithilingam M
Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S469-73. PubMed ID: 26929583
[TBL] [Abstract][Full Text] [Related]
23. Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
Mehta M; Griffith J; Panneerselvam J; Babu A; Mani J; Herman T; Ramesh R; Munshi A
Int J Radiat Biol; 2021; 97(8):1109-1120. PubMed ID: 32052681
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
25. Antitumor compounds from Streptomyces sp. KML-2, isolated from Khewra salt mines, Pakistan.
Aftab U; Zechel DL; Sajid I
Biol Res; 2015 Oct; 48():58. PubMed ID: 26466995
[TBL] [Abstract][Full Text] [Related]
26. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
Taeger J; Moser C; Hellerbrand C; Mycielska ME; Glockzin G; Schlitt HJ; Geissler EK; Stoeltzing O; Lang SA
Mol Cancer Ther; 2011 Nov; 10(11):2157-67. PubMed ID: 21885862
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Multi-Faceted Potential of Carob (
Elbouzidi A; Taibi M; Ouassou H; Ouahhoud S; Ou-Yahia D; Loukili EH; Aherkou M; Mansouri F; Bencheikh N; Laaraj S; Bellaouchi R; Saalaoui E; Elfazazi K; Berrichi A; Abid M; Addi M
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375787
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant and apoptotic effects of Callistemon lanceolatus leaves and their compounds against human cancer cells.
Ahmad K; Hafeez ZB; Bhat AR; Rizvi MA; Thakur SC; Azam A; Athar F
Biomed Pharmacother; 2018 Oct; 106():1195-1209. PubMed ID: 30119188
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the anticancer potential of secondary metabolites from
Kalra R; Conlan XA; Gupta M; Areche C; Bhat M; Goel M
Nat Prod Res; 2022 Dec; 36(24):6439-6442. PubMed ID: 35147447
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2.
Abd Elhameed AA; Ali AR; Ghabbour HA; Bayomi SM; El-Gohary NS
Drug Dev Res; 2023 Dec; 84(8):1664-1698. PubMed ID: 37661648
[TBL] [Abstract][Full Text] [Related]
31. TCA Cycle and Its Relationship with Clavulanic Acid Production: A Further Interpretation by Using a Reduced Genome-Scale Metabolic Model of
Ramirez-Malule H; López-Agudelo VA; Gómez-Ríos D; Ochoa S; Ríos-Estepa R; Junne S; Neubauer P
Bioengineering (Basel); 2021 Jul; 8(8):. PubMed ID: 34436106
[No Abstract] [Full Text] [Related]
32. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs).
Wang X; Chen Z; Tong L; Tan S; Zhou W; Peng T; Han K; Ding J; Xie H; Xu Y
Eur J Med Chem; 2013 Jul; 65():477-86. PubMed ID: 23770449
[TBL] [Abstract][Full Text] [Related]
33. Construction and analysis of ss-lactamase-inhibitory protein (BLIP) non-producer mutants of Streptomyces clavuligerus.
Thai W; Paradkar AS; Jensen SE
Microbiology (Reading); 2001 Feb; 147(Pt 2):325-335. PubMed ID: 11158349
[TBL] [Abstract][Full Text] [Related]
34. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
35. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
36. Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
Hänze J; Kessel F; Di Fazio P; Hofmann R; Hegele A
Biomed Pharmacother; 2018 Oct; 106():316-325. PubMed ID: 29966976
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Al-Hussain SA; Farghaly TA; Zaki MEA; Abdulwahab HG; Al-Qurashi NT; Muhammad ZA
Bioorg Chem; 2020 Dec; 105():104330. PubMed ID: 33038552
[TBL] [Abstract][Full Text] [Related]
38. Activation of Secondary Metabolite Gene Clusters in
Martínez-Burgo Y; Santos-Aberturas J; Rodríguez-García A; Barreales EG; Tormo JR; Truman AW; Reyes F; Aparicio JF; Liras P
Front Microbiol; 2019; 10():580. PubMed ID: 30984130
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
40. Design and green synthesis of novel quinolinone derivatives of potential anti-breast cancer activity against MCF-7 cell line targeting multi-receptor tyrosine kinases.
Mokhtar M; Alghamdi KS; Ahmed NS; Bakhotmah D; Saleh TS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1454-1471. PubMed ID: 34210212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
